ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Isomorphic Labs, the Alphabet drug discovery company run by Demis Hassabis, raised $5bn in a Series C round co-led by Greenoaks and Sequoia Capital on Tuesday. This funding follows a $2.1bn raise in May and includes new investors like Andreessen Horowitz.
Tap to vote and see what everyone thinks.
Summary by ByteBrief